As BCL6 is a proto-oncogene that is strongly implicated in the pathogenesis of human DLBCL [25–27], we hypothesized that BCL6 might be a novel substrate of FBW7 in B cells. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.